Literature DB >> 31332785

Optogenetic stimulation of serotonin nuclei retrieve the lost memory in Alzheimer's disease.

Mehmet Bostancıklıoğlu1.   

Abstract

How are memories stored and retrieved? It was one of the most discussed questions in the past century by neuroscientists. Leading studies of the period brought two different explanations to this question: The first statement considers memory as a physiological change in the brain and suggest that the retrieval of memory is only occurred by the same physiologic changes observed during the memory formation, while the second suggests that memory is a psychic mood stored in mind and the retrieval of memory is occurred by mystical energy fluctuations. Although the exact reason and the pathogenesis of Alzheimer's disease have not yet been fully understood, the approaches that centered the retrieval strategy of lost memory constitutes the basis of the treatment strategies in Alzheimer's disease today. The majority of treatment studies has based on the manipulation of the cholinergic system; however, although serotonin has mnemonic effects, its role in the pathogenesis of Alzheimer's disease has not been investigated as much as the cholinergic system. Here we show how serotonin affects the pathogenesis of Alzheimer's disease in a comprehensive perspective and we suggest that the optogenetics manipulation of serotonin nuclei retrieve the lost memory by closing the inward-rectifier potassium channel Kir2 on the memory engram cells. Also, we raise the possible effects of serotonin on the memory engram cells and the interactions between the amyloid-centric hypothesis of Alzheimer's disease and the memory engram hypothesis to explain the pathophysiology of memory loss in Alzheimer's disease.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  Alzheimer's disease; memory engram cells; memory retrieval; optogenetic; serotonin

Year:  2019        PMID: 31332785     DOI: 10.1002/jcp.29077

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  6 in total

1.  Current Topics of Optogenetics for Medical Applications Toward Therapy.

Authors:  Toshihiro Kushibiki
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  The Roles of Serotonin in Neuropsychiatric Disorders.

Authors:  Mahsa Pourhamzeh; Fahimeh Ghasemi Moravej; Mehrnoosh Arabi; Elahe Shahriari; Soraya Mehrabi; Richard Ward; Reza Ahadi; Mohammad Taghi Joghataei
Journal:  Cell Mol Neurobiol       Date:  2021-03-02       Impact factor: 5.046

Review 3.  EDR Peptide: Possible Mechanism of Gene Expression and Protein Synthesis Regulation Involved in the Pathogenesis of Alzheimer's Disease.

Authors:  Vladimir Khavinson; Natalia Linkova; Ekaterina Kozhevnikova; Svetlana Trofimova
Journal:  Molecules       Date:  2020-12-31       Impact factor: 4.411

4.  Engineered Bacteriorhodopsin May Induce Lung Cancer Cell Cycle Arrest and Suppress Their Proliferation and Migration.

Authors:  Chui-Wei Wong; Ling-Ning Ko; Hung-Jin Huang; Chii-Shen Yang; Shan-Hui Hsu
Journal:  Molecules       Date:  2021-12-03       Impact factor: 4.411

Review 5.  Optogenetics: implications for Alzheimer's disease research and therapy.

Authors:  Parsa Mirzayi; Parnian Shobeiri; Amirali Kalantari; George Perry; Nima Rezaei
Journal:  Mol Brain       Date:  2022-02-23       Impact factor: 4.041

6.  Three-Week Treadmill Exercise Enhances Persistent Inward Currents, Facilitates Dendritic Plasticity, and Upregulates the Excitability of Dorsal Raphe Serotonin Neurons in ePet-EYFP Mice.

Authors:  Renkai Ge; Yue Dai
Journal:  Front Cell Neurosci       Date:  2020-10-16       Impact factor: 5.505

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.